NIH Offers Licensing Agreements to Commercialize Technologies - NIH makes available a full range of licenses for commercial evaluation and for the sale of commercial products and services. - BioPharm

ADVERTISEMENT

NIH Offers Licensing Agreements to Commercialize Technologies
NIH makes available a full range of licenses for commercial evaluation and for the sale of commercial products and services.


BioPharm International
Volume 20, Issue 3

14. For a list of the NIH Technology Development Coordinators for each of the Institutes and Centers and their contact information, see http://www.ott.nih.gov/nih_staff/tdc.html

15. Conflict of Interest Information and Resources. Washington, DC: NIH. Available from: http://www.nih.gov/about/ethics_COI.htm

16. 15 USC 3710a.

17. 28 USC 209(e).

18. For these and other success stories, see http://www.ott.nih.gov/about_nih/success_stories.html

19. Cooperative Research and Development Agreements and Material Transfer Agreements. Washington, DC: NIH. Available from: http://www.ott.nih.gov/cradas/model_agree.html

20. The Government won a court challenge to keep company proprietary information from disclosure under the Freedom of Information Act. Public Citizen Health Research Group vs. National Institutes of Health and Johnson & Johnson, U.S. Ct D.C., March 12, 2002. Available from: http://www.ott.nih.gov/foia/PCHRGopinion.pdf


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here